Previous 10 | Next 10 |
Gilead Sciences (GILD) is trading ~1.6% higher in the pre-market after Bernstein upgraded the stock to outperform from market perform.The analyst Aaron Gal expects that company to generate future catalysts and growth drivers the lack of which led the stock to remain undervalued in the pa...
Healthcare supply chain and pharma services companies weathered the COVID-19 volatility fairly well, and adapted to new realities along the way, Baird notes with the Q4 results in the rear-view mirror. The contract research organizations posted constant-dollar organic revenue growth of 10.2% ...
ICON plc , (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations, today announced that Mr. Brendan Brennan, CFO of ICON plc, will prese...
CFRA analyst Sel Hardy has upgraded ICON Public Limited ([[ICLR]] +3.5%) to hold from sell noting that the stock witnessed more than a tenth of a decline in value since the previous sell call in the wake of its merger agreement with PRA Health.The price target, lowered to $178.00 from $1...
Merger activity increased last week. Six multi-billion-dollar deals announced. SPAC frenzy hits a new record. For further details see: Merger Arbitrage Mondays: SPAC IPOs Set A New Record
ICON Public Limited Company (ICLR) Q4 2020 Earnings Conference Call February 25, 2020 09:00 AM ET Company Participants Jonathan Curtain - VP Corporate Finance & IR Steve Cutler - CEO Brendan Brennan - CFO Colin Shannon - Chairman and CEO, PRA Health Sciences Conference Call Participants R...
The following slide deck was published by ICON Public Limited Company in conjunction with their 2020 Q4 earnings call. For further details see: ICON Public Limited Company 2020 Q4 - Results - Earnings Call Presentation
Immediate reaction to yesterday's announcement of a big merger of healthcare contract research organizations has Baird raising targets on each company, saying it looks like two good firms with an interesting case for coming together. Initial feedback on the deal for ICON plc's (ICLR) $12B acq...
Image source: The Motley Fool. Icon PLC (NASDAQ: ICLR) Q4 2020 Earnings Call Feb 25, 2021 , 9:00 a.m. ET Operator Continue reading For further details see: Icon PLC (ICLR) Q4 2020 Earnings Call Transcript
Looking For The Best Health Care Stocks To Watch Right Now? 4 Names To Know You can’t deny that health care is a vital industry in the world we live in today. Similarly, health care stocks have and will likely continue to fill the same role in the stock market. With all e...
News, Short Squeeze, Breakout and More Instantly...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry awards recognising the company’s leadership position in the clinical research industry, in addi...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2024 after the market closes on Wednesday, July 24, 2024. The company will hold a conference call and webcas...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET. Any changes to this event and links...